Genmab A (GMAB) Cash from Financing Activities (2018 - 2026)

Genmab A (GMAB) has reported Cash from Financing Activities for 8 consecutive years, with -$75.0 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Cash from Financing Activities rose 82.1% year-over-year to -$75.0 million; the trailing twelve-month figure through Jun 2026 stood at -$1.1 billion (up 28.87% YoY), and the FY2025 full-year result was $4.8 billion, up 946.11% from the prior year.
• Cash from Financing Activities grew to -$75.0 million in Q2 2026 per GMAB's latest filing, from -$177.0 million in the prior quarter.
• Across five years, Cash from Financing Activities topped out at $12.2 million in Q4 2022 and bottomed at -$611.0 million in Q1 2023.
• Historically, Cash from Financing Activities has averaged -$257.9 million across 5 years, with a median of -$133.0 million in 2023.
• The sharpest annual moves came in 2022 and 2024: Cash from Financing Activities jumped 576.17% in 2022, then sank 30553.03% in 2024.
• Over 5 years, Cash from Financing Activities stood at $12.2 million in 2022, then slumped by 828.04% to -$89.0 million in 2023, then sank by 535.96% to -$566.0 million in 2024, then grew by 22.26% to -$440.0 million in 2025, then soared by 82.95% to -$75.0 million in 2026.
• According to Business Quant data, Cash from Financing Activities over the past three periods registered -$75.0 million, -$177.0 million, and -$440.0 million for Q2 2026, Q1 2026, and Q3 2025 respectively.